project id: TCGA-BRCA; case submitter id: TCGA-AR-A2LH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.4; rna integrity number: 9.0; age at index: 55; days to birth: -20288; days to death: 616; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1952; year of death: 2008; age at diagnosis: 20288; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1661; days to sample procurement: 0; initial weight: 1100.0; portion submitter id: TCGA-AR-A2LH-01A-31; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 47.0; percent tumor cells: 50.0; percent tumor nuclei: 80.0;